FDA Clearance Tracker · P930038-S024
ANGIO-SEAL
Last checked: Nov 20, 2026Latest source record: Mar 23, 2000 (this decision)Source: openFDAMethods & limitations
Decided
Mar 23, 2000
Approved
Time to decision
16 days
Received Mar 7, 2000. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P930038-S024
- Device name
- ANGIO-SEAL
- Applicant
- Terumo Medical Corporation
- Applicant location
- Elkton, MD
- Received
- Mar 7, 2000
- Decided
- Mar 23, 2000
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Express GMP Supplement
- Original approval
- P930038
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for an alternate sterilization facility located at SteriGenics International, Inc., Gurnee, Illinois.
Source documents
Other decisions for Terumo Medical Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MISAGO(TM) RX Self-expanding Peripheral StentPMA supplement
P140002-S032 · Decided Jul 16, 2026 · 199 days after receipt · Panel Track
Device type: STENT, ILIAC (NIO) · Cardiology
P210017 · Decided Sep 26, 2023 · 880 days after receipt
Device type: Device, hemostasis, vascular (MGB) · Cardiology
- R2P Navicross510(k)
K231044 · Decided Jul 27, 2023 · 106 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.